Recap: Emergent BioSolutions Q2 Earnings

Emergent BioSolutions EBS reported its Q2 earnings results on Monday, August 1, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Emergent BioSolutions missed estimated earnings by 332.43%, reporting an EPS of $-0.86 versus an estimate of $0.37.

Revenue was down $154.80 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.06 which was followed by a 11.55% drop in the share price the next day.

Here's a look at Emergent BioSolutions's past performance:

 

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate 0.12 4.27 2.35 1.54
EPS Actual 0.18 4.50 -0.36 0.33
Revenue Estimate 283.00M 691.36M 486.84M 398.93M
Revenue Actual 307.50M 723.20M 329.00M 397.50M

To track all earnings releases for Emergent BioSolutions visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!